Medicine by its Russian trade name
Keppra (Кеппра) and alternatives in France
In France the medicine is sold under the same name, Keppra. The active ingredient is levetiracetam.
The antiepileptic levetiracetam as tablets and oral solution. Prescription only.
- Packages in the catalog
- 19 packages
- Forms
- Film-coated tablet, Concentrate for solution for infusion, Oral solution
- Dispensing in France
- Prescription only
- Supply in France
- No shortages reported by ANSM
Forms and strengths in France
According to the official BDPM catalog. Packages declared as supplied to the French market come first. A manager confirms availability.
Alternatives to Keppra: medicines with the same active ingredient
Medicines registered in France with the same active ingredients (levetiracetam), according to the official BDPM catalog. Strengths, forms and excipients may differ; agree any substitution with your doctor.
- LEPTAXFilm-coated tablet · 250 mg, 500 mg, 750 mg, 1000 mg
- LEVETIRACETAM ACCORDFilm-coated tablet · 250 mg, 500 mg, 1000 mg
- LEVETIRACETAM ACCORDOral solution · 100 mg/ml
- LEVETIRACETAM ARROWConcentrate for solution for infusion · 100 mg/ml
- LEVETIRACETAM ARROWOral solution · 100 mg/ml
- LEVETIRACETAM ARROW LABFilm-coated tablet scored · 250 mg, 500 mg, 1000 mg
- LEVETIRACETAM ARROW LABConcentrate for solution for infusion · 100 mg/ml
- LEVETIRACETAM BIOGARANFilm-coated tablet scored · 250 mg, 500 mg, 1000 mg
- LEVETIRACETAM CRISTERSFilm-coated tablet scored · 250 mg, 500 mg, 1000 mg
- LEVETIRACETAM CRISTERS PHARMAFilm-coated tablet scored · 500 mg
- LEVETIRACETAM EGFilm-coated tablet · 250 mg, 500 mg, 1000 mg
- LEVETIRACETAM EGOral solution · 100 mg/ml
Showing 12 of 31. All medicines with levetiracetam →
Active ingredient
Why Кеппра may be missing from Russian pharmacies
A medicine can disappear from Russian pharmacies when its registration lapses or is suspended, the manufacturer leaves the market, supplies are interrupted or procurement changes. LekInfo does not track stock in Russian pharmacies: we show which forms and strengths are registered in France according to the official BDPM database and help you work it out in a consultation.
Prescription
In France Keppra is a prescription-only medicine. Prescribing is a doctor’s decision; a manager will tell you which documents the consultation needs.
How to get a consultation about Keppra
- 1. Find a medicine
Search by name, active ingredient or code. Information comes from BDPM, the official French medicines database.
- 2. Build a list
Add the medicines you have questions about to your consultation list and set the quantities.
- 3. Send a request
Choose how to reach you: email, Telegram, WhatsApp or phone. No account needed.
- 4. Get a manager’s reply
A manager will clarify the medicine details, check that they are current and explain the possible options. We usually reply within 2 hours during working hours.
Questions and answers
Where can I find Кеппра if Russian pharmacies have none?
In France Keppra is registered and listed in the official BDPM database: the catalog has 19 packages. Send a request to a manager, who will check that the information is current and explain the possible options. The consultation is free; we usually reply within 2 hours during working hours.
How much does Keppra cost in France?
Reference guide: ≈ €35 – €96 per package depending on form and strength. This is BDPM reference data excluding delivery, not an offer to sell; a manager confirms the final terms.
What alternatives to Keppra exist in France?
BDPM lists medicines with the same active ingredients (levetiracetam): Keppra, Leptax, Levetiracetam Accord and others. Strengths and forms may differ; agree any substitution with your doctor.
Is a prescription needed for Keppra?
Yes, in France Keppra is prescription-only. A manager will tell you which documents are needed.
Is Keppra the same as Кеппра?
Yes, it is the same medicine under the same name; the active ingredient is levetiracetam. Strengths and forms in France may differ from Russian ones, so check them against your prescription.
This is reference information, not advertising or an offer to sell, and it does not replace a doctor’s advice. Source: BDPM, the official French medicines database (ANSM), catalog version of 2 November 2026.